DocGo (DCGO) Stock Forecast, Price Target & Predictions
DCGO Stock Forecast
DocGo stock forecast is as follows: an average price target of $8.75 (represents a 144.41% upside from DCGO’s last price of $3.58) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
DCGO Price Target
The average price target for DocGo (DCGO) is $8.75 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $5.00. This represents a potential 144.41% upside from DCGO's last price of $3.58.
DCGO Analyst Ratings
According to 2 Wall Street analysts, DocGo's rating consensus is 'Buy'. The analyst rating breakdown for DCGO stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
DocGo Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 09, 2024 | Richard Close | Canaccord Genuity | $5.00 | $3.50 | 42.86% | 39.66% |
| Apr 10, 2024 | David Grossman | Stifel Nicolaus | $8.00 | $3.17 | 152.45% | 123.46% |
| Apr 10, 2024 | David Larsen | BTIG | $11.00 | $3.85 | 185.71% | 207.26% |
| Apr 19, 2022 | - | Deutsche Bank | $11.00 | $8.11 | 35.64% | 207.26% |
The latest DocGo stock forecast, released on May 09, 2024 by Richard Close from Canaccord Genuity, set a price target of $5.00, which represents a 42.86% increase from the stock price at the time of the forecast ($3.50), and a 39.66% increase from DCGO last price ($3.58).
DocGo Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $8.00 |
| Last Closing Price | $3.58 | $3.58 | $3.58 |
| Upside/Downside | -100.00% | -100.00% | 123.46% |
In the current month, the average price target of DocGo stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to DocGo's last price of $3.58. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 09, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Sep 19, 2023 | BTIG | Buy | Buy | Hold |
DocGo's last stock rating was published by Canaccord Genuity on May 09, 2024. The company gave DCGO a "Buy" rating, the same as its previous rate.
DocGo Financial Forecast
DocGo Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $199.25T | $186.55T | $125.49M | $113.00M | $108.78M | $104.32M | - | $117.89M | $121.32M |
| Avg Forecast | $117.13M | $120.29M | $117.73M | $119.06M | $108.41M | $103.76M | $102.35M | $107.40M | $127.68M | $137.92M | $163.38M | $187.95M | $194.21M | $147.69M | $119.77M | $111.53M | $104.90M | $97.77M | $97.94M | $103.84M | $81.06M |
| High Forecast | $124.08M | $127.43M | $124.72M | $126.14M | $114.84M | $109.92M | $108.43M | $113.78M | $135.26M | $144.39M | $173.09M | $199.11M | $195.33M | $156.46M | $126.89M | $118.15M | $111.13M | $103.58M | $97.94M | $111.73M | $87.21M |
| Low Forecast | $112.36M | $115.40M | $112.94M | $114.22M | $104.00M | $99.54M | $98.19M | $103.03M | $122.48M | $133.88M | $156.74M | $180.30M | $192.28M | $141.68M | $114.90M | $106.99M | $100.63M | $93.80M | $97.94M | $97.99M | $76.48M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 3 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1025912.34% | 1263122.95% | 1.05% | 1.01% | 1.04% | 1.07% | - | 1.14% | 1.50% |
DocGo's average Quarter revenue forecast for Mar 24 based on 4 analysts is $187.95M, with a low forecast of $180.30M, and a high forecast of $199.11M. DCGO's average Quarter revenue forecast represents a -100.00% decrease compared to the company's last Quarter revenue of $199.25T (Dec 23).
DocGo EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 3 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $16.82T | $13.49T | $5.51M | $-3.20M | $6.39M | $9.00M | - | $12.35M | $24.86M |
| Avg Forecast | $-6.18M | $-6.34M | $-6.21M | $-6.28M | $-5.72M | $-5.47M | $-5.40M | $-5.66M | $-6.73M | $-7.27M | $-8.62M | $-9.91M | $-10.24M | $-7.79M | $-6.32M | $-5.88M | $-5.53M | $-5.16M | $-5.16M | $7.32M | $-4.27M |
| High Forecast | $-5.93M | $-6.09M | $-5.96M | $-6.02M | $-5.48M | $-5.25M | $-5.18M | $-5.43M | $-6.46M | $-7.06M | $-8.27M | $-9.51M | $-10.14M | $-7.47M | $-6.06M | $-5.64M | $-5.31M | $-4.95M | $-5.16M | $8.78M | $-4.03M |
| Low Forecast | $-6.54M | $-6.72M | $-6.58M | $-6.65M | $-6.06M | $-5.80M | $-5.72M | $-6.00M | $-7.13M | $-7.61M | $-9.13M | $-10.50M | $-10.30M | $-8.25M | $-6.69M | $-6.23M | $-5.86M | $-5.46M | $-5.16M | $5.86M | $-4.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -1642118.53% | -1732429.70% | -0.87% | 0.54% | -1.15% | -1.75% | - | 1.69% | -5.82% |
4 analysts predict DCGO's average Quarter EBITDA for Mar 24 to be $-9.91M, with a high of $-9.51M and a low of $-10.50M. This is -100.00% lower than DocGo's previous annual EBITDA (Dec 23) of $16.82T.
DocGo Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 3 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $16.40T | $13.68T | $-2.01M | $-3.92M | $8.06M | $2.47M | - | $10.63M | $20.27M |
| Avg Forecast | $4.25M | $5.91M | $5.79M | $6.06M | $4.43M | $3.74M | $3.42M | $5.05M | $5.09M | $5.09M | $6.76M | $8.58M | $10.68M | $6.25M | $3.11M | $1.89M | $7.52M | $4.82M | $3.96M | $6.94M | $196.82M |
| High Forecast | $4.58M | $6.36M | $6.24M | $6.53M | $4.77M | $4.03M | $3.69M | $5.44M | $5.48M | $5.48M | $7.29M | $9.24M | $13.97M | $6.73M | $3.35M | $2.03M | $8.10M | $5.19M | $3.96M | $8.33M | $216.26M |
| Low Forecast | $4.03M | $5.60M | $5.48M | $5.74M | $4.19M | $3.55M | $3.24M | $4.78M | $4.82M | $3.82M | $6.41M | $8.12M | $7.40M | $5.92M | $2.94M | $1.79M | $7.12M | $4.56M | $3.96M | $5.55M | $182.39M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1534882.62% | 2190163.75% | -0.65% | -2.08% | 1.07% | 0.51% | - | 1.53% | 0.10% |
DocGo's average Quarter net income forecast for Mar 24 is $8.58M, with a range of $8.12M to $9.24M. DCGO's average Quarter net income forecast represents a -100.00% decrease compared to the company's last Quarter net income of $16.40T (Dec 23).
DocGo SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 3 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $43.72T | $35.23T | $33.89M | $33.17M | $37.30M | $24.48M | - | $26.47M | $30.64M |
| Avg Forecast | $41.76M | $42.89M | $41.97M | $42.45M | $38.65M | $36.99M | $36.49M | $38.29M | $45.52M | $49.17M | $58.25M | $67.01M | $69.24M | $52.66M | $42.70M | $39.76M | $37.40M | $34.86M | $34.92M | $16.41M | $28.90M |
| High Forecast | $44.24M | $45.43M | $44.47M | $44.97M | $40.95M | $39.19M | $38.66M | $40.57M | $48.22M | $51.48M | $61.71M | $70.99M | $69.64M | $55.78M | $45.24M | $42.12M | $39.62M | $36.93M | $34.92M | $19.69M | $31.09M |
| Low Forecast | $40.06M | $41.14M | $40.27M | $40.72M | $37.08M | $35.49M | $35.01M | $36.73M | $43.67M | $47.73M | $55.88M | $64.28M | $68.55M | $50.52M | $40.97M | $38.15M | $35.88M | $33.44M | $34.92M | $13.13M | $27.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 631371.20% | 668959.83% | 0.79% | 0.83% | 1.00% | 0.70% | - | 1.61% | 1.06% |
DocGo's average Quarter SG&A projection for Mar 24 is $67.01M, based on 4 Wall Street analysts, with a range of $64.28M to $70.99M. The forecast indicates a -100.00% fall compared to DCGO last annual SG&A of $43.72T (Dec 23).
DocGo EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 3 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $131.73K | $-0.02 | $-0.04 | $0.08 | $0.02 | - | $0.11 | $0.20 |
| Avg Forecast | $0.04 | $0.06 | $0.05 | $0.06 | $0.04 | $0.04 | $0.03 | $0.05 | $0.05 | $0.05 | $0.06 | $0.08 | $0.10 | $0.06 | $0.03 | $0.02 | $0.07 | $0.05 | $0.04 | $0.05 | $1.89 |
| High Forecast | $0.04 | $0.06 | $0.06 | $0.06 | $0.04 | $0.04 | $0.03 | $0.05 | $0.05 | $0.05 | $0.07 | $0.09 | $0.13 | $0.06 | $0.03 | $0.02 | $0.08 | $0.05 | $0.04 | $0.06 | $2.08 |
| Low Forecast | $0.04 | $0.05 | $0.05 | $0.05 | $0.04 | $0.03 | $0.03 | $0.04 | $0.05 | $0.04 | $0.06 | $0.08 | $0.07 | $0.06 | $0.03 | $0.02 | $0.07 | $0.04 | $0.04 | $0.05 | $1.75 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2241810.52% | -0.66% | -2.15% | 1.13% | 0.55% | - | 2.18% | 0.11% |
According to 5 Wall Street analysts, DocGo's projected average Quarter EPS for Dec 23 is $0.10, with a low estimate of $0.07 and a high estimate of $0.13. This represents a -100.00% decrease compared to DCGO previous annual EPS of $131.73K (Sep 23).
DocGo Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| DCGO | DocGo | $3.57 | $8.75 | 145.10% | Buy |
| MODV | ModivCare | $13.46 | $25.33 | 88.19% | Buy |
| MD | Pediatrix Medical Group | $10.55 | $18.40 | 74.41% | Hold |
| HCSG | Healthcare Services Group | $11.53 | $17.33 | 50.30% | Hold |
| EHAB | Enhabit | $8.00 | $10.25 | 28.13% | Hold |
| SEM | Select Medical | $34.91 | $40.00 | 14.58% | Buy |
| INNV | InnovAge | $5.95 | $6.80 | 14.29% | Hold |
| EHC | Encompass Health | $91.32 | $93.17 | 2.03% | Buy |
| PNTG | Pennant Group | $34.67 | $30.67 | -11.54% | Buy |
| ENSG | Ensign Group | $152.03 | $124.40 | -18.17% | Buy |
DCGO Forecast FAQ
Is DocGo a good buy?
Yes, according to 2 Wall Street analysts, DocGo (DCGO) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of DCGO's total ratings.
What is DCGO's price target?
DocGo (DCGO) average price target is $8.75 with a range of $5 to $11, implying a 144.41% from its last price of $3.58. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will DocGo stock go up soon?
According to Wall Street analysts' prediction for DCGO stock, the company can go up by 144.41% (from the last price of $3.58 to the average price target of $8.75), up by 207.26% based on the highest stock price target, and up by 39.66% based on the lowest stock price target.
Can DocGo stock reach $5?
DCGO's average twelve months analyst stock price target of $8.75 supports the claim that DocGo can reach $5 in the near future.
What are DocGo's analysts' financial forecasts?
DocGo's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $421.92M (high $446.97M, low $404.75M), average EBITDA is $-22.25M (high $-21.345M, low $-23.571M), average net income is $16.64M (high $17.93M, low $15.76M), average SG&A $150.43M (high $159.36M, low $144.31M), and average EPS is $0.157 (high $0.169, low $0.148). DCGO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $474.21M (high $502.37M, low $454.92M), average EBITDA is $-25.008M (high $-23.99M, low $-26.493M), average net income is $22.01M (high $23.71M, low $20.85M), average SG&A $169.07M (high $179.11M, low $162.19M), and average EPS is $0.207 (high $0.223, low $0.196).
Did the DCGO's actual financial results beat the analysts' financial forecasts?
Based on DocGo's last annual report (Dec 2023), the company's revenue was $624.29T, beating the average analysts forecast of $573.21M by 108911581.19%. Apple's EBITDA was $34.41T, missing the average prediction of $-30.228M by -113831786.39%. The company's net income was $22.54T, beating the average estimation of $21.92M by 102801290.20%. Apple's SG&A was $139.95T, beating the average forecast of $204.37M by 68481539.03%. Lastly, the company's EPS was $213.39K, beating the average prediction of $0.206 by 103488745.78%. In terms of the last quarterly report (Dec 2023), DocGo's revenue was $199.25T, beating the average analysts' forecast of $194.21M by 102591133.80%. The company's EBITDA was $16.82T, missing the average prediction of $-10.242M by -164211952.54%. DocGo's net income was $16.4T, beating the average estimation of $10.68M by 153488161.96%. The company's SG&A was $43.72T, beating the average forecast of $69.24M by 63137019.63%. Lastly, the company's EPS was $0, missing the average prediction of $0.1 by -100.00%